Furthermore, bevacizumab inhibits VEGF activity, resulting in the normalization of abnormal tumor tissue structure, microenvironment and vasculature, thereby facilitating chemotherapy drug absorption and reducing tumor metastasis [1]. This evidence concerns the gene VEGFA and neoplasm.